Table 2.
Case | Author | Year | Age | Sex | Histologic type | Stage | Adjuvant chemotherapy | Time of recurrence after gastrectomy (months) | No. of metastasis | Treatment | Prognosis after recurrence (months) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Sudo | 1993 | 61 | M | Adenocarcinoma | N/A | N/A | 60 | Solitary | CRT | 6 | Dead |
2 | Amano | 1996 | 57 | M | Adenocarcinoma | N/A | N/A | 7 | Multiple | N/A | N/A | Dead |
3 | Ghanekar | 1997 | 75 | M | por | IIA | N/A | 15 | Solitary | Surgery | 1 | Alive |
4 | Beşe | 2006 | 60 | M | sig | IIA | 5-FU, leucovorin | 13 | Multiple | CRT | 11 | Alive |
5 | Koga | 2015 | 71 | M | por | IB | None | 36 | Multiple | Chemotherapy | 1 | Dead |
6 | Kamitani | 2018 | 47 | M | por | IIA | S-1 | 12 | Multiple | Chemotherapy | 7 | Dead |
7 | Our case | 2020 | 79 | M | tub2 > por | IIIA | None | 36 | Solitary | Surgery | 42 | Alive |
M male, por poorly differentiated adenocarcinoma, sig signet ring cell carcinoma, tub2 moderately differentiated adenocarcinoma, N/A not available, CRT chemoradiotherapy